Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Quality Systems, Inc.    QSII

News SummaryMost relevantAll newsSector newsTweets

Quality Systems, Inc. : to Present at Leerink Swann 2013 Global Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
02/06/2013 | 11:05am CEST

Quality Systems, Inc. (NASDAQ: QSII) announced today that its management plans to present its corporate story at the Leerink Swann 2013 Global Healthcare Conference.

The conference, which will showcase nearly 150 publicly traded and privately held healthcare companies for institutional investors, is scheduled for Wednesday, February 13, 2013 - Thursday, February 14, 2013 at The Waldorf=Astoria in New York City. Quality Systems' President and Chief Executive Officer Steven T. Plochocki is scheduled to present on Wednesday, February 13, 2013, at 8:00 AM local time. The 25-minute presentation will address the company's operations and strategy.

A webcast of Quality Systems' audio presentation will be available on February 13, 2013 (beginning at the start time of the presentation) and can be viewed by accessing http://leerink.metameetings.com/webcasts/healthcare13/directlink?p=123. It will be archived for 90 days.

Founded in 1995, Leerink Swann, member FINRA/SIPC, is a leading healthcare investment bank to a broad range of institutional, life sciences, corporate and high-net-worth clients. For more information, visit www.leerink.com.

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit www.qsii.com and www.nextgen.com for additional information.


This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2012, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Quality Systems, Inc.
Susan J. Lewis, 303-804-0494
[email protected]

© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on QUALITY SYSTEMS, INC.
10/17 QUALITY SYSTEMS, INC. : Announces Time Change for Fiscal 2018 Second Quarter Res..
10/12 QUALITY SYSTEMS, INC. : to Host Fiscal 2018 Second Quarter Results Conference Ca..
09/19 QUALITY : WLF Reminds Ninth Circuit of Congressional Intent When Applying the PS..
09/12 QUALITY : Center for Devices and Radiological Health Premarket Approval Applicat..
09/11 QUALITY SYSTEMS, INC. : to Host Analyst Day on Thursday, September 14, 2017
08/31 QUALITY : Health Initiatives Consulting Partners with NextGen Healthcare
08/23 QUALITY SYSTEMS, INC : Change in Directors or Principal Officers, Submission of ..
08/23 QUALITY : Julie Klapstein Elected to Quality Systems Board of Directors
08/22 QUALITY SYSTEMS, INC. : to Present at Upcoming Investor Conference
08/17 QUALITY : Tunnell Consulting Joins Top Industry Experts at ISPE Conference
More news
News from SeekingAlpha
09/14 Quality Systems (QSII) Investor Presentation - Slideshow
08/19 Stocks to watch next week
08/16 NextGen Healthcare closes deal for EagleDream Health
08/01 Quality Systems' (QSII) CEO Rusty Frantz on Q1 2018 Results - Earnings Call T..
08/01 Quality Systems beats by $0.01, beats on revenue
Financials ($)
Sales 2018 525 M
EBIT 2018 62,7 M
Net income 2018 17,8 M
Finance 2018 20,4 M
Yield 2018 -
P/E ratio 2018 55,68
P/E ratio 2019 42,77
EV / Sales 2018 1,83x
EV / Sales 2019 1,64x
Capitalization 978 M
Duration : Period :
Quality Systems, Inc. Technical Analysis Chart | QSII | US7475821044 | 4-Traders
Technical analysis trends QUALITY SYSTEMS, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 15
Average target price 15,1 $
Spread / Average Target -2,5%
EPS Revisions
John R. Frantz President, Chief Executive Officer & Director
Jeffrey H. Margolis Chairman
Scott E. Bostick Chief Operating Officer & Executive VP
James R. Arnold Chief Financial & Accounting Officer
David A. Metcalfe Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
ACCENTURE17.32%88 603
VMWARE, INC.49.12%47 683